Cabazitaxel regimens inhibit the growth of prostate cancer cells and enhances the anti‐tumor properties of PEDF with various efficacy and toxicity
Year: 2018
Type: article
Source: The Prostate
DOI: 10.1002/pros.23647
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2800869553
